From: Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
Antibodies level (IgG) | Patients | Controls | p | |||
---|---|---|---|---|---|---|
n | % | n | % | |||
EBVCA | negative | 6 | 5.5 | 0 | 0 | >0.05 |
low | 24 | 21.8 | 14 | 35.0 | ||
high | 80 | 72.7 | 26 | 65.0 | ||
EBNA | negative | 4 | 3.6 | 0 | 0 | >0.05 |
low | 23 | 20.9 | 12 | 30.0 | ||
high | 83 | 75.5 | 28 | 70.0 | ||
EA | negative | 6 | 5.5 | 31 | 77.5 | <0.05* |
low | 27 | 24.5 | 9 | 22.5 | ||
high | 77 | 70.0 | 0 | 0 |